Cite
HARVARD Citation
Kojima, T. et al. (2018). Phase I dose‐escalation trial of Sym004, an anti‐EGFR antibody mixture, in Japanese patients with advanced solid tumors. Cancer science. 109 (10), pp. 3253-3262. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kojima, T. et al. (2018). Phase I dose‐escalation trial of Sym004, an anti‐EGFR antibody mixture, in Japanese patients with advanced solid tumors. Cancer science. 109 (10), pp. 3253-3262. [Online].